AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Intro
This chapter discusses a biopharmaceutical company's breakthroughs in immuno-oncology, particularly their recent FDA submission for a treatment targeting recurrent respiratory papillomatosis. The use of gorilla adenovectors for genetic delivery is also explored, showcasing their potential benefits for future therapies.